Table 6. Cost to detect one colorectal neoplasia.
| Annual FIT scheme (N = 5,863) | Colonoscopy scheme (N = 4,869) | ICER with FIT as control | |||
|---|---|---|---|---|---|
| All | |||||
| Findings | N | Cost per finding | N | Cost per finding | |
| Screening Cost | US$1,225,369 | US$4,433,875 | |||
| Adenoma | 93 | 13,176 | 1,151 | 4,271 | 3,489 |
| AN | 56 | 21,882 | 188 | 26,151 | 27,962 |
| CRC | 10 | 122,537 | 14 | 357,172 | 922,762 |
| AN + CRC Stage 1 | 61 | 21,521 | 218 | 23,294 | 23,981 |
| Moderate Risk | (N = 4,940) | (N = 3,805) | |||
| Screening Cost | US$1,026,448 | US$3,792.324 | |||
| Adenoma | 70 | 14,664 | 839 | 4,520 | 3,597 |
| AN | 46 | 22,314 | 116 | 32,692 | 39,513 |
| CRC | 8 | 128,306 | 7 | 541,761 | Dominated by FIT |
| AN + CRC Stage 1 | 50 | 21,925 | 137 | 28,514 | 32,297 |
| High Risk | (N = 923) | (N = 1,064) | |||
| Screening Cost | US$199,184 | US$1,119,993 | |||
| Adenoma | 20 | 9,959 | 312 | 3,590 | 3,153 |
| AN | 10 | 19,918 | 72 | 15,555 | 14,852 |
| CRC | 2 | 99,592 | 7 | 159,999 | 184,162 |
| AN + CRC Stage 1 | 11 | 19,708 | 79 | 14,720 | 13,919 |
FIT: Faecal Immunochemical Tests; CRC: Colorectal Cancer; ICER: Incremental Cost-Effectiveness Ratio; AN: advanced neoplasia.